June 14 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO
* Says would have to assess any offer that comes for core
assets, focused on non-core asset sales
* CEO says already had inbound phone calls, emails
expressing interest in Valeant assets
* CEO says has a "number of bankers" working on non-core
asset sales
Source text for Eikon:
Further company coverage: VRX.TO